New MS Study Shows TYSABRI Improves Cognitive Impairment

13 Jul

Read about the finding that natalizumab therapy over a period of three years can improve cognitive impairment in MS patients.

Sourced through from:

One of the challenges regarding DMTs (disease modifying treatments) for #MS is the uncertainty regarding the exact means by which the DMTs slow progression of the disease. Because these mechanisms are not known with certainty, any additional information we can gain regarding the effects of DMTs on #MS or or symptoms helps move us closer to understanding the disease, ways to treat it, and, hopefully, toward a cure.

See on Scoop.itOvercoming Multiple Sclerosis

Leave a comment

Posted by on 13 July 2015 in Uncategorized


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: